XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 30.98

+3.9%

Dec 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (16222)	7/5/2003 2:20:13 AM
From: Cacaito	Read Replies (1) of 17367

Amevive sales now projected lower to: $40M in 2003 $80M in 2004 $175 in 2005 $280 in 2006 Still quite good, but it could be tempering xomaDna Raptiva prospects. Dna hardly talks about Raptiva, analyst covering Dna mentioned it as the ugly duck in the prospects for adding to the bottomline. xoma is a buy under $5, sell above $8

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next